Related Experiment Video
Updated: Feb 26, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
4.3K
The MOGE(S) classification for cardiomyopathies: current status and future outlook
Julian G Westphal1, Angelos G Rigopoulos2,3, Constantinos Bakogiannis4
1Department of Internal Medicine I, Division of Cardiology, Pneumology, Angiology and Intensive Medical Care, University Hospital Jena, Friedrich-Schiller-University Jena, Am Klinikum, 107747, Jena, Germany.
Heart Failure Reviews
|July 20, 2017
Summary
The MOGE(S) classification system aids in understanding complex cardiomyopathies by integrating genetic, acquired, and environmental factors. This review explores its clinical relevance and potential future updates for improved cardiomyopathy diagnosis and management.
Area of Science:
- Cardiology
- Genetics
- Pathology
Background:
- Cardiomyopathies are complex diseases with high morbidity and mortality.
- Previous classifications focused primarily on phenotypic characterization.
- Advances in understanding genetic and acquired causes necessitate updated classification systems.
Purpose of the Study:
- To review the development and cornerstones of the MOGE(S) classification system.
- To summarize published data on the clinical relevance of the MOGE(S) classification.
- To discuss potential future updates for the MOGE(S) classification.
Main Methods:
- Literature review of the MOGE(S) classification system.
- Analysis of published data on its clinical utility.
- Discussion of emerging concepts for future revisions.
Main Results:
- The MOGE(S) classification integrates morphofunctional, organ, genetic, etiological, and heart failure status.
- It provides a comprehensive framework for classifying cardiomyopathies.
- Published data support its clinical relevance in understanding disease complexity.
Conclusions:
- The MOGE(S) classification is a valuable tool for characterizing cardiomyopathies.
- It facilitates a deeper understanding of multifactorial disease pathogenesis.
- Future updates should consider emerging knowledge to refine its application.
More Related Videos
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
700
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
700
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
651
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
651
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
565
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
565
01:29Cardiomyopathy V: Interprofessional Care
534
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
534
01:30Cardiomyopathy II: Dilated Cardiomyopathy
667
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
667
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
4.4K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.4K